1. Home
  2. PCSC vs ASRT Comparison

PCSC vs ASRT Comparison

Compare PCSC & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCSC
  • ASRT
  • Stock Information
  • Founded
  • PCSC 2024
  • ASRT 1995
  • Country
  • PCSC United States
  • ASRT United States
  • Employees
  • PCSC N/A
  • ASRT N/A
  • Industry
  • PCSC
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCSC
  • ASRT Health Care
  • Exchange
  • PCSC NYSE
  • ASRT Nasdaq
  • Market Cap
  • PCSC 108.6M
  • ASRT 105.8M
  • IPO Year
  • PCSC 2024
  • ASRT 1997
  • Fundamental
  • Price
  • PCSC $10.12
  • ASRT $0.81
  • Analyst Decision
  • PCSC
  • ASRT Strong Buy
  • Analyst Count
  • PCSC 0
  • ASRT 4
  • Target Price
  • PCSC N/A
  • ASRT $3.19
  • AVG Volume (30 Days)
  • PCSC 7.4K
  • ASRT 862.2K
  • Earning Date
  • PCSC 01-01-0001
  • ASRT 11-11-2024
  • Dividend Yield
  • PCSC N/A
  • ASRT N/A
  • EPS Growth
  • PCSC N/A
  • ASRT N/A
  • EPS
  • PCSC N/A
  • ASRT N/A
  • Revenue
  • PCSC N/A
  • ASRT $125,763,000.00
  • Revenue This Year
  • PCSC N/A
  • ASRT N/A
  • Revenue Next Year
  • PCSC N/A
  • ASRT $4.68
  • P/E Ratio
  • PCSC N/A
  • ASRT N/A
  • Revenue Growth
  • PCSC N/A
  • ASRT N/A
  • 52 Week Low
  • PCSC $10.02
  • ASRT $0.73
  • 52 Week High
  • PCSC $10.12
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • PCSC N/A
  • ASRT 30.77
  • Support Level
  • PCSC N/A
  • ASRT $0.82
  • Resistance Level
  • PCSC N/A
  • ASRT $1.07
  • Average True Range (ATR)
  • PCSC 0.00
  • ASRT 0.07
  • MACD
  • PCSC 0.00
  • ASRT -0.02
  • Stochastic Oscillator
  • PCSC 0.00
  • ASRT 8.29

About PCSC PERCEPTIVE CAP SOLUTIONS CORP

Perceptive Capital Solutions Corp is a blank check company.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: